Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders

• Status: Unknown status
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Stress-related disorders are among the most prevalent and expensive medical consequences of participation in military operations. Omega-3 fatty acids EPA/DHA derived from fish oil are known to benefit both neuronal development in the young, and cognition and mood in various populations.

It is possible that soldiers receiving Omega-3 EPA/DHA will exhibit significantly higher cognitive performance, better affect/mood state, and less combat stress symptomatology compared to the placebo after 12 weeks of supplementation. A goal would be to reduce the prevalence of combat stress injuries in military personnel.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: United States Department of Defense
• Collaborator: GlaxoSmithKline

Criteria

Inclusion Criteria:

• US Army deployed personnel

• score on a mood questionnaire

Exclusion Criteria:

• currently consume omega-3 fish oil supplements

• are currently taking antidepressant or other medications for psychiatric purposes

• pregnant

• known fish or shellfish allergy